ACI-24

AssetVaccine

Liposomal anti-amyloid-beta vaccine designed to elicit antibodies against amyloid-beta to prevent or clear plaques

Stage
Phase 1
Modality
Vaccine
Target
APP
Indications
1
Trials
1
Developers
1

Indications

1
  • Targets and what it contains2
  • Owner and partners4
  • Trials1
  • Evidence for its targets2
  • Competitors8
  • Aging relevance1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 2 sources

Assets